BioCentury
ARTICLE | Clinical News

Supratek begins esophagus cancer Phase II

November 15, 2001 8:00 AM UTC

Supratek (Montreal, Quebec) began an open-label, U.K. Phase II trial of its SP1049C biotransport carrier version of doxorubicin to treat adenocarcioma of the esophagus. ...